- Home
- / Jiangsu Hengrui Pharmaceuticals
Jiangsu Hengrui Pharmaceuticals
Stock Price
¥48.2
2024-10-29
Market Capitalization
¥301.2 B
2024-10-29
Revenue
¥27.7 B
FY, 2025
Jiangsu Hengrui Pharmaceuticals Summary
Company Summary
- Overview
- Jiangsu Hengrui Pharmaceuticals (江苏恒瑞医药股份有限公司) is a company that manufactures and distributes pharmaceutical tablets, injections, and raw materials. It offers surgical and antineoplastic drugs, anti-tumor, antibiotics, cardiovascular medication, etc.
- Type
- Public
- Status
- Active
- Founded
- 1970
- HQ
- Lianyungang, CN | view all locations
- Website
- https://www.hengrui.com
- Cybersecurity rating
Table of Contents
LocationsView all
1 location detected
Lianyungang, Jiang Su Sheng HQ
China
No.7 Kunlunshan Road, Lianyungang Eco & Tech Development Zone
Jiangsu Hengrui Pharmaceuticals Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥8.1B
- Gross profit (Q1, 2026)
- ¥7.0B
- Net income (Q1, 2026)
- ¥2.3B
- Cash (Q1, 2026)
- ¥40.5B
- EBIT (Q1, 2026)
- ¥2.6B
- Enterprise value
- $260.8B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026